Q&A session: Audience: attendees at ECToH Basel 2007
Q: Should we be advocating more clinical effort into Tobacco Control rather than re-allocating Tobacco Control monies − this is not an either:or approach? A: PT: We have to calculate the cost-effectiveness from both perspectives. In the clinical arena, the cost of smoking cessation is £1k per QualityAdjusted Life Years (QALY), this calculation is necessary to convince payers to provide funding, and it is used as argument to support reimbursement. LC: There is no argument from the panel about the need for all aspects of Tobacco Control policy to be utilised; it’s a question of the relative priority and emphasis each deserves.